167 related articles for article (PubMed ID: 34060423)
21. Protein methylation and interaction with the antiproliferative gene, BTG2/TIS21/Pc3.
Paik WK; Kim S; Lim IK
Yonsei Med J; 2014 Mar; 55(2):292-303. PubMed ID: 24532495
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of mRNA deadenylation: evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylases.
Funakoshi Y; Doi Y; Hosoda N; Uchida N; Osawa M; Shimada I; Tsujimoto M; Suzuki T; Katada T; Hoshino S
Genes Dev; 2007 Dec; 21(23):3135-48. PubMed ID: 18056425
[TBL] [Abstract][Full Text] [Related]
23. Anti-proliferative protein Tob negatively regulates CPEB3 target by recruiting Caf1 deadenylase.
Hosoda N; Funakoshi Y; Hirasawa M; Yamagishi R; Asano Y; Miyagawa R; Ogami K; Tsujimoto M; Hoshino S
EMBO J; 2011 Apr; 30(7):1311-23. PubMed ID: 21336257
[TBL] [Abstract][Full Text] [Related]
24. Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton.
Tijchon E; van Ingen Schenau D; van Opzeeland F; Tirone F; Hoogerbrugge PM; Van Leeuwen FN; Scheijen B
PLoS One; 2015; 10(7):e0131481. PubMed ID: 26218146
[TBL] [Abstract][Full Text] [Related]
25. The enzyme activities of Caf1 and Ccr4 are both required for deadenylation by the human Ccr4-Not nuclease module.
Maryati M; Airhihen B; Winkler GS
Biochem J; 2015 Jul; 469(1):169-76. PubMed ID: 25944446
[TBL] [Abstract][Full Text] [Related]
26. Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity.
Yang X; Morita M; Wang H; Suzuki T; Yang W; Luo Y; Zhao C; Yu Y; Bartlam M; Yamamoto T; Rao Z
Nucleic Acids Res; 2008 Dec; 36(21):6872-81. PubMed ID: 18974182
[TBL] [Abstract][Full Text] [Related]
27. Biological role of the two overlapping poly(A)-binding protein interacting motifs 2 (PAM2) of eukaryotic releasing factor eRF3 in mRNA decay.
Osawa M; Hosoda N; Nakanishi T; Uchida N; Kimura T; Imai S; Machiyama A; Katada T; Hoshino S; Shimada I
RNA; 2012 Nov; 18(11):1957-67. PubMed ID: 23019593
[TBL] [Abstract][Full Text] [Related]
28. BTG/TOB factors impact deadenylases.
Mauxion F; Chen CY; Séraphin B; Shyu AB
Trends Biochem Sci; 2009 Dec; 34(12):640-7. PubMed ID: 19828319
[TBL] [Abstract][Full Text] [Related]
29. Emerging role of anti-proliferative protein BTG1 and BTG2.
Kim SH; Jung IR; Hwang SS
BMB Rep; 2022 Aug; 55(8):380-388. PubMed ID: 35880434
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative protein Tob directly regulates c-myc proto-oncogene expression through cytoplasmic polyadenylation element-binding protein CPEB.
Ogami K; Hosoda N; Funakoshi Y; Hoshino S
Oncogene; 2014 Jan; 33(1):55-64. PubMed ID: 23178487
[TBL] [Abstract][Full Text] [Related]
31. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
32. B-cell translocation gene 2 (BTG2) stimulates cellular antioxidant defenses through the antioxidant transcription factor NFE2L2 in human mammary epithelial cells.
Karve TM; Rosen EM
J Biol Chem; 2012 Sep; 287(37):31503-14. PubMed ID: 22493435
[TBL] [Abstract][Full Text] [Related]
33. Evidence providing new insights into TOB-promoted deadenylation and supporting a link between TOB's deadenylation-enhancing and antiproliferative activities.
Ezzeddine N; Chen CY; Shyu AB
Mol Cell Biol; 2012 Mar; 32(6):1089-98. PubMed ID: 22252318
[TBL] [Abstract][Full Text] [Related]
34. The central region of CNOT1 and CNOT9 stimulates deadenylation by the Ccr4-Not nuclease module.
Pavanello L; Hall B; Airhihen B; Winkler GS
Biochem J; 2018 Nov; 475(21):3437-3450. PubMed ID: 30309886
[TBL] [Abstract][Full Text] [Related]
35. CAF1 plays an important role in mRNA deadenylation separate from its contact to CCR4.
Ohn T; Chiang YC; Lee DJ; Yao G; Zhang C; Denis CL
Nucleic Acids Res; 2007; 35(9):3002-15. PubMed ID: 17439972
[TBL] [Abstract][Full Text] [Related]
36. PRMT1 and Btg2 regulates neurite outgrowth of Neuro2a cells.
Miyata S; Mori Y; Tohyama M
Neurosci Lett; 2008 Nov; 445(2):162-5. PubMed ID: 18773938
[TBL] [Abstract][Full Text] [Related]
37. Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation.
Passeri D; Marcucci A; Rizzo G; Billi M; Panigada M; Leonardi L; Tirone F; Grignani F
Mol Cell Biol; 2006 Jul; 26(13):5023-32. PubMed ID: 16782888
[TBL] [Abstract][Full Text] [Related]
38. The BTG2-PRMT1 module limits pre-B cell expansion by regulating the CDK4-Cyclin-D3 complex.
Dolezal E; Infantino S; Drepper F; Börsig T; Singh A; Wossning T; Fiala GJ; Minguet S; Warscheid B; Tarlinton DM; Jumaa H; Medgyesi D; Reth M
Nat Immunol; 2017 Aug; 18(8):911-920. PubMed ID: 28628091
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines.
Cho BO; Jeong YW; Kim SH; Park K; Lee JH; Kweon GR; Park JC
Oncol Rep; 2008 Mar; 19(3):633-7. PubMed ID: 18288394
[TBL] [Abstract][Full Text] [Related]
40. The RNA binding domain of Pumilio antagonizes poly-adenosine binding protein and accelerates deadenylation.
Weidmann CA; Raynard NA; Blewett NH; Van Etten J; Goldstrohm AC
RNA; 2014 Aug; 20(8):1298-319. PubMed ID: 24942623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
